Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun
Tetrahydrobiopterin .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word sapropterin.
Examples
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt
BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease - Yahoo! Finance 2011
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt,
-
The Phase 3b study is a double-blind, placebo-controlled, randomized 28-week study (2-week screening period, 13-week randomized treatment period, 13-week open-label treatment period) to evaluate the safety and therapeutic effects of sapropterin dihydrochloride on neuropsychiatric symptoms in subjects with PKU.
THE MEDICAL NEWS 2010
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt,
Medindia Health News 2010
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt,
Medindia Health News 2010
-
Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt,
-
BioMarin today that it has received notice of priority review status for Kuvan (R) (sapropterin dihydrochloride) as today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL
WN.com - Articles related to BioMarin to buy Huxley Pharmaceuticals 2009
-
BioMarin today that it has received notice of priority review status for Kuvan (R) (sapropterin dihydrochloride) as today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL
WN.com - Articles related to BioMarin to buy Huxley Pharmaceuticals 2009
-
April 30/PRNewswire-FirstCall/-- today that data from clinical studies of Kuvan (R) (sapropterin dihydrochloride) and Naglazyme (R)
WN.com - Articles related to BioMarin to buy Huxley Pharmaceuticals 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.